Canamasas Makes Trident Return for Barcelona Test
Another name with a large experience of junior formulae has become the final driver added to the list of drivers beginning Formula 2’s pre-season test.
Sergio Canamasas will make his return to the Trident team in the first test at the Circuit de Barcelona-Catalunya on March 13-15.
The Spanish driver partners Nabil Jeffri at the team with its second seat standing as the last one remaining empty on the F2 grid.
It will be Canamasas’ first drive in the series’ GP2-11 chassis since racing in the then-GP2 Series in Abu Dhabi last November. He did not take part in post-season testing last December, with the currently unattached Philo Paz Armand testing for all three days of the test for the team.
Canamasas previously made 19 starts for Trident during the 2014 season as part of his 90 appearances in the series between 2012 and 2016.
Team manager Giacomo Ricci believes that having someone in the car with this amount of knowledge of the GP2-11 chassis is key for their development before the start of the new F2 season.
“We completed an impressive amount of work during the winter break, he said. “The three-day test on such a technical track like Montmelo will be key to evaluate some of the technical solutions we identified in the past weeks.
“We will also count on the experience and undisputed professionalism of Sergio Canamasas to start the season with the best possible outlook.”
DOWN TO 10
Meanwhile, only 10 teams are appearing at the test despite Hilmer Motorsport’s previously-announced intention to return to Formula 1’s feeder series in 2017.
The team – which competed in GP2 from 2013 to 2015, with Canamasas as one of their drivers in their final season – had outlined plans to return to racing last November.
EMAIL CAMERON AT @email@example.com
FOLLOW ON TWITTER: @PatersonCameron
The thoughts and opinions expressed here are those of the author and do not necessarily reflect those of PopularSpeed.com, its owners, management or other contributors. Any links contained in this article should not be considered an endorsement.